CLA 90 caps

Doel
CLA is een vetbron die kan helpen om gewicht te verliezen samen met een dieet en trainingsprogramma
Werking
• CLA vermindert de gewichtstoename
• CLA verhoogt de vetvrije massa (spiermassa)
• CLA vermindert het vetgehalte in het lichaam
• CLA stabiliseert het lichaamsgewicht
Gebruik
Gebruik: neem 3 maal per dag 2 capsules bij de maaltijden.
Verpakking:
Pot met 90 capsules van 1000mg CLA
INGREDIËNTEN: geconjugeerd linolzuur 80%, gelatine, oplosmiddel : glycerol en sorbitolsiroop.

Energy/Voedingswaarde/Analyse/	6 caps
Energie / valeur énergétique	60.18 Kcal / 247.92 KJ
Eiwit / Protéine	1127.94 mg
Koolhydraten / Glucides	689.7 mg
Vet / Lipides	6000 mg
CLA	6000 mg

REFERENCES
1. Pariza M, Ashoor S, Chu F, Lund D. Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett 1979;7:63–9.
2. Cunningham DC, Harrison LY, Shultz TD. Proliferative responses of normal human mammary and MCF-7 breast cancer cells to linoleic acid, conjugated linoleic acid and eicosanoid synthesis inhibitors in culture. Anticancer Res 1997;17:197–203.
3. Liew C, Schut HA, Chin SF, Pariza MW, Dashwood RH. Protection of conjugated linoleic acids against 2-amino-3- methylimidazo[4,5-
f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 1995;16:3037–43.
4. Ip C, Singh M, Thompson HJ, Scimeca JA. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the
mammary gland in the rat. Cancer Res 1994;54:1212–5.
5. Schonberg S, Krokan HE. The inhibitory effect of conjugated dienoic derivatives (CLA) of linoleic acid on the growth of human tumor cell lines is in part due to increased lipid peroxidation. Anticancer Res 1995; 15:1241–6.
6. Wong MW, Chew BP, Wong TS, Hosick HL, Boylston TD, Shultz TD. Effects of dietary conjugated linoleic acid on lymphocyte function and growth of mammary tumors in mice. Anticancer Res 1997;17:987–93.
7. Zu HX, Schut HA. Inhibition of 2-amino-3-methylimidazo[4,5- f]quinoline-DNA adduct formation in CDF1 mice by heat-altered derivatives of linoleic acid. Food Chem Toxicol 1992;30:9–16.
8. Nicolosi RJ, Rogers EJ, Kritchevsky D, Scimeca JA, Huth PJ. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 1997;22:266–77.
9. Lee KN, Kritchevsky D, Pariza MW. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 1994;108:19–25.
10. Cook ME, Miller CC, Park Y, Pariza M. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Poult Sci 1993;72:1301–5.
11. Miller CC, Park Y, Pariza MW, Cook ME. Feeding conjugated linoleic acid. Biochem Biophys Res Commun 1994;198:1107–12.
12. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 1998; 244:678–82.(Published erratum appears in Biochem Biophys Res Commun 1998;247:911.)
13. DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol 1999;276:R1172–9.
14. Ostrowska E, Suster D, Muralitharan M, et al. Conjugated linoleic acid decreases fat accretion in pigs: evaluation by dual-energy X-ray absorptiometry. Br J Nutr 2003;89:219–29.
15. Akahoshi A, Goto Y, Murao K, et al. Conjugated linoleic acid reduces body fats and cytokine levels of mice. Biosci Biotech Biochem 2002; 66:916–20.
16. Corino C, Mourot J, Magni S, Pastorelli G, Rosi F. Influence of dietary conjugated linoleic acid on growth, meat quality, lipogenesis, plasma leptin and physiological variables of lipid metabolism in rabbits. J Anim Sci 2002;80:1020–8.
17. Takahashi Y, Kushiro M, Shinohara K, Ide T. Dietary conjugated linoleic acid reduces body fat mass and affects gene expression of proteins regulating energy metabolism in mice. Comp Biochem Physiol B Biochem Mol Biol 2002;133:395–404.
18. Rahman S, Wang Y, Han S, et al. Effects of short-term administration of conjugated linoleic acid on lipid metabolism in white and brown adipose tissues of starved/refed Otsuka Long-Evans Tokushima fatty rats. Food Res Int 2001;34:515–20.
19. Dugan MER, Aalhus JL, Schaefer AL, Kramer JKG. The effects of conjugated linoleic acid on fat to lean repartitioning and feed conversion in pigs. Can J Anim Sci 1997;77:723–5.
20. Gavino VC, Gavino G, Leblanc MJ, Tuchweber B. An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr 2000;130:27–9.
21. Park Y, Storkson JM, Albright KJ, Liu W, ParizaMW.Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999;34:235–41.
22. West DB, DeLany JP, Camet PM, Blohm F, Truett AA, Scimeca J. Effects of conjugated linoleic acid on body fat and energy  metabolism in the mouse. Am J Physiol 1998;275:R667–72.
23. Szymczyk B, Pisulewski PM, Szczurek W, Hanczakowski P. Effects of conjugated linoleic acid on growth performance, feed conversion efficiency, and subsequent carcass quality in broiler chickens. Br J Nutr 2001;85:465–73.
24. Gaullier J-M, Berven G, Blankson H, Gudmundsen O. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids 2002;37: 1019–25.
25. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000;130:2943–8.
26. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans—metabolic effects. Lipids 2001;36:773–81.
27. Berven G, Bye A, Hals O, et al. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol 2000;102:455–62.
28. Zambell KL, Keim NL, Van Loan MD, et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 2000;35:777–82.
29. Atkinson RL. Conjugated linoleic acid for altering body composition and treating obesity. In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ, eds. Advances in conjugated linoleic acid research. Vol 1. Champaign, IL: AOCS Press, 1999:348–53.
30. Kreider RB, Ferreira MP, Greenwood M, Wilson M, Almada AL. Effects of conjugated linoleic acid supplementation during resistancetraining on body composition, bone density, strength, and selected haematological markers. J Strength Cond Res 2002;3:325–34.
31. Lowery LM, Appicelli PA, Lemon PWR. Conjugated linoleic acid enhances muscle size and strength gains in novice bodybuilders. Med Sci Sports Exerc 1998;30:182(abstr).
32. Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistancein obese men with the metabolic syndrome. Diabetes Care 2002;25:1516–21.
33. Terpstra AH. Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. J Nutr 2001;131:2067–8.
34. Basu S, Smedman A, Vessby B. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 2000;468:33–6.
35. Basu S, Riserus U, Turpeinen A, Vessby B. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci
(Lond) 2000;99:511–6.
36. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002;106:1925–9.
37. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–97.
38. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
1124 GAULLIER ET AL 39. Nes M, Andersen LF, Solvoll K, et al. Accuracy of a quantitative food frequency questionnaire applied in elderly Norwegian women. Eur J Clin Nutr 1992;46:809–21.
40. Reseland J, Anderssen S, Solvoll K, et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 2001;73:240–5.
41. Montgomery D. Design and analysis of experiments. 2nd edition. New York: John Wiley & Sons, 1984.
42. Gresti A. Categorical data analysis. New York: John Wiley & Sons, 1990.
43. Kendall M, Stuart A. The advance theory of statistics. Vol 3. London: Charles Griffin & Co Ltd, 1979.
44. Tylavsky F, Lohman T, Dockrell M, et al. Comparison of the effectiveness of 2 dual-energy X-ray absorptiometers with that of total body water and computed tomography in assessing changes in body composition during weight change. Am J Clin Nutr 2003;77:356–63.
45. Evans M, Geigerman C, Cook J, Curtis L, Kuebler B, McIntosh M. Conjugated linoleic acid suppresses triglyceride accumulation and induces apoptosis in 3T3–L1 preadipocytes. Lipids 2000;35:899–910.
46. Park Y, Pariza MW. The effects of dietary conjugated nonadecadienoic acid on body composition in mice. Biochim Biophys Acta 2001;1533: 171–4.
47. Kallen C, Lazar M. Antidiabetic thiazolidinediones inhibit leptin ob gene expression in 3T3–L1 adipocytes. Proc Natl Acad Sci U S A
1996;93:5793–6.
48. Granlud L, Juvet L, Pedersen J, Nebb H. Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by
acting as a PPARgamma modulator. J Lipid Res 2003;44:1441–52.
49. Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 2001;29:392–6.
50. Vessby B, Smedman A. Conjugated linoleic acid (CLA) reduces the body fat content in humans. Chem Phys Lipids 1999;101:152(abstr).
51. Noone EJ, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002;88:243–51.
52. Wilson P,D’Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–47.
53. Hackam D, Anand SS. Emerging risk factors for atherosclerosic vascular disease: a critical review of the evidence. JAMA 2003;290:932–40.
54. Munday JS, Thompson KG, James KA. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr 1999;81:251–5.
55. Kritchevsky D, Tepper SA, Wright S, Tso P, Czarnecki SK. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 2000;19:472S–7S.
56. Hontecillas R, Wannemeulher MJ, Zimmerman DR, et al. Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J Nutr 2002;132:2019–27.
57. Whigham LD, Higbee A, Bjorling DE, Park Y, Pariza MW, Cook ME. Decreased antigen-induced eicosanoid release in conjugated linoleic acid-fed guinea pigs. Am J Physiol Regul Integr Comp Physiol 2002; 282:R1104–12.
58. Turek J, Li Y, Schoenlein I, Allen K, Watkins B. Modulation of macrophage cytokine production by conjugated linoleic acids is influenced by the dietary n_6:n_3 fatty acid ratio. J Nutr Biochem 1998;9:258–66.
59. Bassaganya-Riera J, Hontecillas R, Zimmerman DR, Wannemuehler MJ. Dietary conjugated linoleic acid modulates phenotype and effector functions of porcine CD8(_) lymphocytes. J Nutr 2001;131:2370–7. 60. Bassaganya-Riera J, Hontecillas-Magarzo R, Bregendahl K, Wannemuehler MJ, Zimmerman DR. Effects of dietary conjugated linoleic acid in nursery pigs of dirty and clean environments on growth, empty body composition, and immune competence. J Anim Sci 2001;79:714–21.
61. Albers R, Van der Wielen RP, Brink EJ, Hendriks HF, Dorovska-Taran VN, Mohede IC. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr 2003;57:595–603.
62. Rissanen A, Heliovaara M, Knekt P, Aromaa A, Reunanen A, Maatela J. Weight and mortality in Finnish men. J Clin Epidemiol 1989;42:781–9.
63. Jonsson S, Hedblad B, Engstrøm G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow up of 22,025menfrom an urban Swedish population. Int J Obes Relat Metab Disord 2002;26:1046–53.
64. Heitman B, Erikson H, Ellsinger B, Mikkelsen K, Larsson B. Mortality associated with body fat, fat-free mass and body mass index among 60-year old Swedish men—a 22-year follow up. The study of men born in 1913. Int J Obes Relat Metab Disord 2000;24:33–7.
65. Gregg E, Gerzoff R, Thompson T, Williamson D. Intentional weight loss and death in overweight and obese US adults 35 years of age and older. Ann Intern Med 2003;138:383–9.

Energy/Voedingswaarde/Analyse/	6 caps
Energie / valeur énergétique	60.18 Kcal / 247.92 KJ
Eiwit / Protéine	1127.94 mg
Koolhydraten / Glucides	689.7 mg
Vet / Lipides	6000 mg
CLA	6000 mg